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DEVELOPING AN ANIMAL MODEL OF ALZEHEIMER'S DISEASE: 
MULTIPLE IDPPOCAMPAL INJECTIONS OF BETA�AMYLOID (l�42) 
AND THE EFFECTS ON SPATIAL LEARNING AND MEMORY IN 
THE MALE RAT. 
Gregory P. Tinkler and Wayne A. Dornan*, Department of Psychology, IWU 
Alzheimer's Disease (AD) is a neurodegenerative disorder which affects 
approximately four million people in the United States alone. A diagnosis of 
AD can be made only by performing a postmortem examination of the brain 
and confirming the presence of high numbers of neuritic plaques and 
neurofibrillary tangles, the pathological hallmarks of the disease. The 
neuritic plaque is composed primarily of the 39- to 43- amino acid protein B­
Amyloid (BA), and is found in large quantities in structures such as the 
hippocampus, which is intimately involved with learning and memory. BA 
has been hypothesized to play a role in the onset of AD, but studies which 
attempt to model the disease using single injections of the peptide fail to 
produce consistent behavioral impairments. A number of recent studies have 
suggested that chronic administration of BA or one of its fragments may be 
more pathologically relevant to AD than single injections, and may also 
produce more consistent impairments of spatial learning and memory. In 
addition, our lab has demonstrated that multiple injections of the neurotoxic 
fragment BA (25-35) into the septum, which projects to the hippocampus, 
produce a marginal impairment on a spatial task. A marginal depletion of 
cholinergic markers in the hippocampus was also produced. Since the BA 
fragment has different chemical properties than the full length peptide, it is 
conceivable that more profound behavioral and neurochemical impairments 
may result from the use of BA (1-42). It is also possible that injections into 
the hippocampus instead of the septum would produce a greater impairment 
on learning and memory. Therefore, this study examines the effects of 
multiple hippocampal injections of the full length BA (1-42) peptide on spatial 
learning and memory in the rat. 
